已核实 DOI PubMed 相关产品: 0

Single-cell transcriptome profiling reveals immune and stromal cell heterogeneity in primary Sjögren's syndrome.

Journal 2023 · IF 5.8 · 26(10): 107943-107943 · 发表于 2023 年 9 月 16 日
作者: Nan Xiang,Hao Xu,Zhou Zhou,Junyu Wang,Pengfei Cai,Li Wang,Zhen Tan,Yingbo Zhou,Tianping Zhang,Jiayuan Zhou,Ke Liu,Songwen Luo,Minghao Fang,Guosheng Wang,Zhuo Chen,Chuang Guo,Xiaomei Li
阅读全文 在 PubMed 查看

摘要

Primary Sjögren's syndrome (pSS) is a complex autoimmune disease characterized by lymphocytic infiltration and exocrine dysfunction, particularly affecting the salivary gland (SG). We employed single-cell RNA sequencing to investigate cellular heterogeneity in 11 patients with pSS and 5 non-SS controls. Notably, patients with pSS exhibited downregulated SOX9 in myoepithelial cells, potentially associated with impaired epithelial regeneration. An expanded ACKR1 + endothelial subpopulation in patients with pSS suggested a role in facilitating lymphocyte transendothelial migration. Our analysis of immune cells revealed expanded IGHD + naive B cells in peripheral blood from patients with pSS. Pseudotime trajectory analysis outlined a bifurcated differentiation pathway for peripheral B cells, enriching three subtypes (VPREB3 + B, BANK1 + B, CD83 + B cells) within SGs in patients with pSS. Fibroblasts emerged as pivotal components in a stromal-immune interaction network, potentially driving extracellular matrix disruption, epithelial regeneration impairment, and inflammation. Our study illuminates immune and stromal cell heterogeneity in patients with pSS, offering insights into therapeutic strategies.